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Abstract 
IL-1 family members regulate innate immune responses, are produced by gestation-
associated tissues, and have a role in healthy and adverse pregnancy outcomes. To better 
understand their role at the materno-fetal interface we used a human tissue explant model to 
map lipopolysaccharide (LPS)-stimulated production of IL-1α, IL-1β, IL-18, IL-33, IL-1Ra, IL-
18BPa, ST2 and IL-1RAcP by placenta, choriodecidua and amnion. Caspase-dependent 
processing of IL-1α, IL-1β, IL-18, and IL-33 and the ability of IL-1α, IL-1β, IL-18, and IL-33 to 
regulate the production of IL-1RA, IL-18BPa, ST2 and IL-1RAcP was also determined. LPS 
acted as a potent inducer of IL-1 family member expression especially in the placenta and 
choriodecidua with the response by the amnion restricted to IL-1β. Caspases-1, 4 and 8 
contributed to LPS-stimulated production of IL-1 and IL-18, whereas calpain was required for 
IL-1 production. Exogenous administration of IL-1α, IL-1β, IL-18, and IL-33 lead to differential 
expression of IL-1Ra, IL-18BPa, ST2 and IL-1RAcP across all tissues examined. Most notable 
were the counter-regulatory effect of LPS on IL-1 and IL-1Ra in the amnion and the broad 
responsiveness of the amnion to IL-1 family cytokines for increased production of 
immunomodulatory peptides and soluble receptors. The placenta and membranes vary not 
only in their output of various IL-1 family members but also in their counter-regulatory 
mechanisms through endogenous inhibitory peptides, processing enzymes and soluble decoy 
receptors. This interactive network of inflammatory mediators likely contributes to innate 
defence mechanisms at the materno-fetal interface to limit, in particular, the detrimental effects 
of microbial invasion. 
 
  
1. Introduction 
Cytokines, including IL-1β, IL-8 and TNFα, produced by gestation-associated tissues 
(placenta and fetal membranes) play key roles in both physiological and pathophysiological 
labour (Patni, Flynn et al. 2007). PROM and preterm delivery of the baby is influenced by the 
overproduction of pro-inflammatory cytokines in response to bacterial infection (Peltier 2003). 
IL-1β was one of the first cytokines evaluated in association with intrauterine infection 
(Romero, Brody et al. 1989) and has been shown to weaken the fetal membranes by up-
regulating apoptosis and essential metalloproteinases (Hoang, Potter et al. 2014).  
IL-1β is a member of the larger 11-membered IL-1 superfamily of cytokines (Netea, Veerdonk 
et al. 2015). The IL-1 subfamily is comprised of IL-1α, IL-1β and IL-33, characterised by their 
larger precursor peptide length. The IL-18 subfamily members display smaller pro-peptides 
and include IL-18 and IL-37. Members of the IL-36 subfamily have the smallest pre-processed 
peptides and this family includes IL-36α, IL-36β, IL-36γ, IL-36Ra and IL-38 (Dinarello, Arend 
et al. 2010). In addition to these three subfamilies of cytokines, IL-1Ra is also included within 
the IL-1 superfamily. 
A common feature of IL-1 family members is their signalling mechanisms, which are initiated 
through a collection of structurally similar receptors containing intracellular Toll/IL-1 receptor 
(TIR) and extracellular immunoglobulin-like (Ig) domains (Sims and Smith 2010). Despite 
these similarities, IL-1 superfamily members differ in how they are processed. IL-1β is initially 
translated as inactive pro-IL-1β that requires cleavage by a caspase-containing inflammasome 
for both secretion and biological activity (Mariathasan, Newton et al. 2004). In contrast, IL-1α 
does not require the removal of a signal peptide for bioactivity and processing of pro-IL-1α 
precursor occurs primarily by calpain, a calcium-dependent cysteine protease (Miller, 
Schattenberg et al. 1994). The processing of pro-IL-18 occurs in a similar inflammasome-
dependent manner to IL-1β (Guo, Callaway et al. 2015). Like other IL-1 family cytokines, IL-
33 is synthesized as a pro-peptide but the role of caspases, calpain and/or other enzymes 
awaits clarification (Cayrol and Girard 2009, Hayakawa, Hayakawa et al. 2009, Zhao and Hu 
2010, Lefrançais, Roga et al. 2012).  
IL-1β, IL-18, IL-33, IL-1Ra, IL-18BP, ST2 and IL-36Ra all have been implicated in physiology 
and pathophysiology of pregnancy. The placenta and/or fetal membranes variably express 
them constitutively or upon activation (Romero, Brody et al. 1989, Ida, Tsuji et al. 2000, 
Granne, Southcombe et al. 2011, Topping, Romero et al. 2013, Southcombe, Redman et al. 
2015). As cytokine production is critical to the success of human pregnancy but also implicated 
in unfavourable obstetric outcomes such as preterm birth and preeclampsia, better 
understanding of the role that IL-1 family cytokines play at the materno-fetal interface is 
essential. To examine this, an explant model of term placenta, choriodecidua and amnion was 
utilised to determine the production, processing and counter regulation of various IL-1 
superfamily members.  
  
2. Methods 
2.1. Placental samples 
Placenta and fetal membrane samples were collected from healthy term newborns (>37 weeks 
of gestation) delivered by ECS at Singleton Hospital, Swansea, UK. Written consent was 
obtained from all study participants following recruitment at the antenatal day assessment unit. 
Ethical approval for this study was given by Wales Research Ethics Committee 6 (REC No. 
11/WA/0040).  
2.2. Tissue explant culture 
Choriodecidua and Amnion. The membrane was detached from the placenta, separated by 
blunt dissection and washed repeatedly in sterile Ca2+ / Mg2+ free phosphate buffered saline 
(PBS; Life Technologies) to remove blood. Explants were cut with an 8-mm biopsy punch 
(Stiefel): two discs of choriodecidua placed into 0.5ml Advanced RPMI supplemented with 
2mM Glutamax, 2mM penicillin streptomycin fungisone (PSF), 5mM 2-mercaptoethanol (2-
ME; all Life Technologies) and 2% fetal bovine serum (FBS; Hyclone) and 5mM 2-
mercaptoethanol; and four discs of amnion placed into 0.5 ml Advanced DMEM (Life 
Technologies) supplemented with 2mM Glutamax, 2mM PSF and 2% FBS.  
Placenta. 1cm3 pieces of placental tissue were taken from different sites across the placenta. 
Tissue pieces were washed in PBS and further diced into smaller 1-2mm3 segments. Diced 
placenta tissue pieces (0.2g) were placed into 1ml Advanced RPMI supplemented with 2mM 
Glutamax, 2mM PSF, 2% FBS and 5mM 2-ME.  
Explant cultures were exposed to different stimuli as detailed in the results; an unstimulated 
control was always included. The following concentrations of stimuli were used; LPS (10 ng/ml; 
ultrapure from E. coli 0111:B4, Invivogen, USA), rhIL-1α, rhIL-1β, rhIL-33 (all 10 ng/ml; Miltenyi 
Biotec, UK) and rhIL-18 (10 ng/ml; Invivogen, USA).  For inhibition experiments cultures were 
treated with inhibitors for caspases 1, 4 and 8 (Z-WEHD-FMK, Z-YVAD-FMK, Z-IETD-FMK; 5 
µM, R&D Systems) or calpain (PD 150606; 1 µM, Tocris) 30 min before the addition of LPS. 
DMSO was used as a vehicle control. Cellular cytotoxicity, determined by lactate 
dehydrogenase assay (Abcam), was not observed with addition of inhibitors or DMSO (data 
not shown). All treatments were performed in duplicate. Cultures were incubated for 24 hours 
at 37°C in 5% CO2. Tissue free supernatants were collected by centrifugation for 7 minutes at 
4°C, 515 x g and stored at -20°C until analysis using cytokine specific ELISAs. 
 
2.3. Cytokine production 
IL-1α, IL-1β, IL-33, IL-1Ra, IL-18BP, IL-1RAcP, and ST2 in tissue free supernatants of 
placenta, choriodecidua and amnion explant cultures collected after 24 h were measured 
using commercially available ELISA kits (DuoSet, R&D Systems) as per manufacturer’s 
instructions. For IL-18, a sandwich ELISA using monoclonal anti-human IL-18 antibody (2 
μg/ml; R&D Systems) and a biotinylated anti-human IL-18 antibody (0.5 μg/ml; R&D Systems) 
was performed as described previously with slight modification (Jitprasertwong, Jaedicke et 
al. 2014). 
2.4. Data analysis 
All experiments were performed a minimum of three times in duplicate with data presented as 
mean ± SEM. Statistical significance was calculated using GraphPad Prism (Version 6, 
GraphPad Software Inc, USA) with appropriate statistical testing determined for each 
experimental output as detailed in the relevant figure legends. A p-value of ≤ 0.05 was 
considered significant.  
  
3. Results 
3.1. Cytokine output of gestational tissues following lipopolysaccharide stimulation 
To examine the production of IL-1 family cytokines by gestation-associated tissues we utilised 
LPS at a concentration of 10 ng/ml (Patni, Wynen et al. 2009). The effects of LPS on levels of 
IL-1α, IL-1𝛽, IL-18, IL-33, IL-1Ra, IL-18BPa, (s)ST2 and IL-1RAcP from the placenta, 
choriodecidua and amnion are summarised in Table 1. In the placenta and choriodecidua, 
there was a significant LPS-stimulated increase in the production of IL-1α, IL-1𝛽, IL-18, and 
IL-33 (Figure1 A-H); in the amnion only IL-1 𝛽 was increased significantly (Figure 1 I-L). IL-
1Ra, IL-18BPa, (s)ST2 and IL-1RAcP were produced from unstimulated cultures for all three 
tissue types. LPS induced a significant increase in IL-1Ra in the placenta (Figure 2A) and 
choriodecidua (Figure 2E) but a decrease in the amnion (Figure 2I). There was no effect of 
LPS on IL-18BPa levels from the placenta, choriodecidua or amnion (Figure 2 B, F & J). LPS 
down-regulated ST2 levels in the placenta (Figure 2C) but not in the choriodecidua or the 
amnion (Figure 2G&K). IL-1RAcP levels were decreased in response to LPS in the placenta 
(Figure 2D) and amnion (Figure 2L) but the choriodecidua showed no change (Figure 2H).  
3.2. Caspase-dependent and -independent processing of IL-1 family cytokines by 
gestational tissues 
Processing of IL-1β and IL-18 is associated with activity of several initiator caspases (caspase-
1, -4, -5, -8 and -12) either directly by canonical and non-canonical inflammasomes or 
indirectly by modulating the activation of these inflammasomes (Man and Kanneganti, 2016). 
Caspase activity can also modulate the production and /or activity of IL-1α and IL-33 (Cayrol 
and Girard 2009, Madouri, Guillou et al. 2015, Man and Kanneganti 2016). To determine 
caspase involvement in the production of IL-1 family cytokine production by gestation-
associated tissues pharmacological inhibitors were used (caspase-1, -4 and -8). As amnion 
produced IL-1only, IL-1, IL-18 and IL-33 were not analysed for this tissue. Caspase 
inhibition had no effect on LPS-stimulated IL-1α levels in the placenta (Figure 3A) or 
choriodecidua (Figure 3E). LPS-stimulated levels of IL-1β and IL-18 in all tissues studied were 
reduced significantly in the presence of inhibitors for each of the caspases of interest (Figure 
3B, C, F, G & I).  Inhibition of caspases-1, 4 and 8 had no effect on LPS-stimulated IL-33 in 
either the placenta (Figure 2D) or choriodecidua (Figure 2H).   
The involvement of calpain in gestational IL-1α processing was examined using a selective 
inhibitor (PD150606, (Low, Karunan Partha et al. 2014)) (Figure 4). As expected, inhibition of 
calpain reduced LPS-stimulated IL-1α levels in the placenta and choriodecidua (the amnion 
was not studied). There was no effect on the production of IL-1𝛽, IL-18 and IL-33. 
3.3. Counter-regulation of IL-1 family cytokines 
IL-1 family cytokines exhibit a broad spectrum of potent biological activities across a range of 
different cells (Afonina, Muller et al. 2015) so their activity is tightly regulated via a number of 
mechanisms. The production of soluble (and ligand) decoy receptors and cytokine receptor 
antagonists provides an effective and efficient means of controlling their inter-cellular 
signalling following the generation of an immune response and in a range of physiological 
processes. Here we examined the effects of IL-1α, IL-1𝛽, IL-18 and IL-33 on IL-Ra, IL-18BPa, 
(s)ST2 and (s)IL-1RAcP levels in gestational tissues. These effects are summarised in Table 
2. For the placenta, IL-1 and IL-1 induced a significant increase in IL-1Ra (Figure 5A) and 
IL-18 an increase in IL-18BPa (Figure 5B); there were no other effects seen. The 
choriodecidua and amnion showed more responsiveness than the placenta. For the 
choriodecidua IL-1α, IL-1𝛽 and IL-18 induced a significant increase in IL-1Ra (Figure 5E), IL-
1α, IL-1𝛽 a significant increase in IL-18BPa (Figure 5F), IL-1α, IL-1𝛽 and IL-33 a significant 
increase in ST2 (Figure 5G), and IL-33 a significant decrease in IL-1RAcP (Figure 5H). For 
the amnion, IL-1α, IL-1, IL-18 and IL-33 all induced a significant increase in IL-1Ra (Figure 
5I), IL-1 𝛽, IL-18 and IL-33 induced an increase in IL-18BPa (Figure 5J), and all four cytokines 
induced an increase in IL-1RAcP (Figure 5L) but had no effect on ST2 levels (Figure 5K).  
  
4. Discussion 
The placenta, choriodecidua and amnion were all responsive to LPS as expected (Patni, 
Wynen et al. 2009, Miller and Loch-Caruso 2010, Hoang, Potter et al. 2014). IL-1α expression 
by choriodecidua has been reported (Zaga-Clavellina, Garcia-Lopez et al. 2007, Holcberg, 
Amash et al. 2008, Hoang, Potter et al. 2014) but greater abundance of IL-1α in the decidua 
(Huleihel, Amash et al. 2004) contrasts with our study with similar levels in placenta and 
choriodecidua. This likely reflects differences in the experimental approach. Basal production 
of IL-18 by various cell types within the placenta has been described in a perfusion model but 
with no stimulating effect of LPS (Amash, Huleihel et al. 2007). The difference to the placental 
LPS-stimulated IL-18 production seen in our study might reflect the experimental model or 
mode of delivery (Ida, Tsuji et al. 2000). Constitutive expression of IL-18 mRNA and 
immunohistochemical localisation within the choriodecidua also has been described but the 
effects of LPS were not considered although PPROM or histological chorioamnionitis did not 
alter levels (Polettini, Vieira et al. 2012). IL-33 expression has been described previously in 
various cell types within the placenta and choriodecidua (Fock, Mairhofer et al. 2013, Topping, 
Romero et al. 2013) but we are the first to show that LPS increases IL-33 levels. Placental 
and decidual macrophages are key IL-33 producers and increase production in response to 
IL-1β (Fock, Mairhofer et al. 2013) so it is perhaps not surprising that LPS also increases IL-
33. IL-33 might have a protective effect in pregnancy, perhaps mediated through enhancing 
the anti-oxidant environment (Zhang, Xie et al. 2012), with down-regulated IL-33-dependent 
signalling through increased (s)ST2 described in preeclampsia (Granne, Southcombe et al. 
2011).  
Some IL-1 superfamily members require enzymatic processing from an immature to mature 
form for biological activity. Caspase-1 inflammasomes have been studied extensively but 
additional caspases allow inflammasomes to operate in a caspase-1-independent manner 
(Kayagaki, Warming et al. 2011). Therefore, we considered the effects of inhibiting caspases-
1, 4 and 8 in gestation-associated tissues. Each inhibitor led to decreased expression of LPS-
stimulated IL-1β in all tissues and IL-18 in placenta and choriodecidua but had no effect on IL-
1 or IL-33. Caspase-1 is reported to inactivate IL-33 (Cayrol and Girard 2009) and caspase-
4 modulates the expression of IL-1α in monocytes (Vigano, Diamond et al. 2015) but we saw 
no evidence of these in our setting. Caspases might have role in adverse pregnancy 
outcomes: caspase-4 is increased in preeclamptic syncytiotrophoblast villi undergoing release 
of apoptotic debris (Burton and Yung 2011); caspase-3 and caspase-8 have been implicated 
in apoptosis in the placenta (Sokolov, Kolobov et al. 2009).  
There is much interest in the natural and therapeutic capability of anti-inflammatory cytokines 
to modulate the inflammatory response within gestation-associated tissues (Bryant, Spencer-
Harty et al. 2017). Therefore, regulation of IL-1Ra, IL-18BP, sST2, and IL-1RAcP was 
investigated. All of these were produced in relative abundance under basal conditions. While 
this could reflect a damage response in the tissue in response to delivery and handling we 
suggest, based on observations of the abundance of IL-1Ra in amniotic fluid (Romero, 
Sepulveda et al. 1992), that it represents genuine constitutive production of these mediators 
by the amnion. LPS stimulated IL-1Ra in the placenta and choriodecidua as described already 
(Fidel, Romero et al. 1994, Holcberg, Amash et al. 2008, Girard, Tremblay et al. 2010) but 
decreased amnion IL-1Ra. Basal expression of IL-1Ra by amnion has been described 
(Holcberg, Amash et al. 2008) but this is the first time the effects of LPS have been shown.  
IL-18BPa, sST2, and IL-1RAcP are much less studied members of the IL-1 family with broad 
counter-regulatory effects. The endogenous inhibitory protein IL-18BPa acts in a similar 
manner to IL-1Ra but binds with high affinity to the IL-18R complex (Garlanda, Dinarello et al. 
2013). The (s)ST2 splice variant acts as a decoy receptor, inhibiting ST2/IL-1RAcP signalling 
(Garlanda, Dinarello et al. 2013). IL-1RAcP is required for IL-1 cytokine binding to receptors 
and downstream signalling and activation of IL-1 responsive genes. (s)IL-1RAcP contributes 
to counter-regulation through increasing the affinity of IL-1 cytokines for the IL-1R2 decoy 
receptor (Garlanda, Dinarello et al. 2013). IL-18BPa, sST2, and IL-1RAcP were produced by 
all three tissue types. To date, the expression of IL-18BPa, sST2, and IL-1RAcP has been 
observed in the placenta (Granne, Southcombe et al. 2011, Topping, Romero et al. 2013, 
Southcombe, Redman et al. 2015), yet only sST2 mRNA expression has been noted in the 
chorio-amniotic membranes (Topping, Romero et al. 2013, Stampalija, Chaiworapongsa et al. 
2014). This is the first study to identify basal expression of IL-18BPa and IL-1RAcP by the 
amnion and choriodecidua. Where LPS had an effect – placental ST2 and IL-1RAcP, and 
amnion IL-1RAcP – it was inhibitory. Given that these molecules tend to inhibit the 
inflammatory response it is not surprising that a potent pro-inflammatory agent such as LPS 
caused a decrease in anti-inflammatory mediators. Other than choriodecidua IL-1RAcP, any 
effect of IL-1α, IL-1𝛽, IL-18 and IL-33 on IL-1RA, IL-18BPa, ST2, and IL-1RAcP tended to be 
stimulatory. This indicates that LPS-mediated inhibition of counter-regulatory IL-1 family 
members is not driven by the inflammatory members of the IL-1 family through negative 
feedback but via some other, as yet undetermined, pathway. Differences in the 
responsiveness of the placenta, choriodecidua and amnion were noted and this might warrant 
further investigation of receptor complexes and downstream signalling pathways. Also, given 
the abundance of IL-1Ra, IL-18BP, ST2 and IL-1RAcP under basal conditions studies wherein 
these are neutralised during the response to LPS or other inflammatory stimuli would provide 
insight into their role in endogenous regulation of inflammation within gestation-associated 
tissues.  
Other IL-1 family members, including IL-36, IL-37 and IL-38, were not analysed in this study. 
Expression of all members of the IL-36 subfamily (IL-36α, IL-36β, IL-36γ, IL-36Ra and IL-38) has 
been described for the placenta, with increased circulating IL-36Ra observed in pregnant 
women (Southcombe, Redman et al. 2015). The effect of LPS on IL-36 sub-family expression 
has yet to be documented in gestational tissues and would be worth further consideration 
especially given their potential contribution to an anti-inflammatory milieu. Similar to IL-1α and 
IL-33, processed IL-37 acts as a dual function cytokine with intracellular (nuclear translocation) 
and extracellular (secreted) anti-inflammatory properties (Nold, Nold-Petry et al. 2010, Bulau, 
Nold et al. 2014). The placenta expresses IL-37 with a reported increase in preeclampsia 
placentas (Southcombe, Redman et al. 2015). 
5. Conclusion 
LPS is a potent inducer of IL-1 family cytokine production in gestation-associated tissues ex 
vivo. Once stimulated, the expression profiles and regulatory systems of bioactivity vary in 
each tissue suggesting difference in receptor clustering and tissue-specific negative regulatory 
processes. As one of the most biologically potent families of cytokines the IL-1 family is subject 
to tight regulation through the presence of signal peptides, natural receptor antagonists, 
signalling inhibitors and soluble decoy receptors. A role for IL-1 family cytokine dysregulation 
in various diseases and obstetric complications such as pre-term birth, PPROM and 
preeclampsia is implicated in many studies (Romero, Sepulveda et al. 1992, Polettini, Vieira 
et al. 2012, Stampalija, Chaiworapongsa et al. 2014, Southcombe, Redman et al. 2015). 
Understanding not only the link between IL-1 family members and the maternal environment, 
but also the role played in orchestrating both adaptive and innate immune responses may be 
important for a range of translational outlooks in both pregnancy and inflammatory disorders. 
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Figure 1. Lipopolysaccharide-induced production of IL-1 family agonists by term non-laboured 
gestation-associated tissues. Explants of placenta (A-D), choriodecidua (E-H) and amnion (I-L) were 
cultured for 24h in basal media ± LPS, with supernatants examined for IL-1α, IL-1𝛽, IL-18 and IL-33 
using specific ELISAs (pg/ml ± SEM; n=10). Statistically significant differences were determined by 
paired t-test; * ≤ 0.05; ** ≤ 0.01; *** ≤ 0.001, **** ≤ 0.001. 
Figure 2. Lipopolysaccharide-induced production of IL-1 family antagonists by term non-
laboured gestation-associated tissues. Explants of placenta (A-D), choriodecidua (E-H) and amnion 
(I-L) were cultured for 24h in basal media ± LPS, with supernatants examined for IL-1Ra, IL-18BPa, 
ST2 and IL-1RAcP using specific ELISAs (pg/ml ± SEM; n=10). Statistically significant differences were 
determined by paired t-test; * ≤ 0.05; ** ≤ 0.01; *** ≤ 0.001, **** ≤ 0.001. 
Figure 3. The involvement of different caspases in lipopolysaccharide-induced IL-1 family 
cytokine production by term non-laboured gestation-associated tissues. Explants of placenta (A-
D), choriodecidua (E-H) and amnion (I) were cultured for 24h in basal media ± LPS, Z-WEHD-FMK 
(caspase-1 inhibitor), Z-YVAD-FMK (caspase-4 inhibitor), Z-IETD-FMK (caspase-8 inhibitor) or vehicle 
(DMSO) control; supernatants were examined for IL-1α, IL-1𝛽, IL-18 and IL-33 using specific ELISAs 
(pg/ml ± SEM; n=4). Statistically significant differences were determined by one-way ANOVA with 
Tukey’s multiple comparison test; * ≤ 0.05; ** ≤ 0.01; *** ≤ 0.001. 
Figure 4. The involvement of calpain in lipopolysaccharide-induced cytokine production by term 
non-laboured gestation-associated tissues. Explants of placenta (A-D), choriodecidua (E-H) and 
amnion (I) were cultured for 24h in basal media ± LPS, PD150606 (calpain inhibitor) or vehicle (DMSO) 
control; supernatants were examined for IL-1α, IL-1𝛽, IL-18 and IL-33 production (pg/ml ± SEM; n=4). 
Statistically significant differences were determined by one-way ANOVA with Tukey’s multiple 
comparison test; * ≤ 0.05; ** ≤ 0.01; *** ≤ 0.001.  
 
Figure 5. Balancing innate immune responses and uncontrolled inflammation in term non-
laboured gestation-associated tissues. Explants of placenta (A-D), choriodecidua (E-H) and amnion 
(I-L) were cultured for 24h in basal media ± IL-1α, IL-1β, IL-18 and IL-33 (10 ng/ml). Supernatants were 
examined for the production of IL-1Ra, IL-18BPa, ST2, and IL-1RAcP using specific ELISAs (pg/ml ± 
SEM; n=5-10). Statistically significant differences were determined by one-way ANOVA with Dunnett’s 
multiple comparison test; * ≤ 0.05; ** ≤ 0.01; *** ≤ 0.001.  **** ≤ 0.001. 
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Table 1. Lipopolysaccharide-induced production of IL-1 family cytokines. 
 
 
 
 
 
 
Table 2. The effects of IL-1 family cytokines on production of regulatory molecules. 
                                IL-RA              IL-18BP                ST2               IL-1RAcP 
 P       C      A P       C       A P       C       A P       C       A 
IL-1α ↑        ↑      ↑ –        ↑       – –        ↑       –  –        –      ↑ 
IL-1β ↑        ↑      ↑ –        ↑       ↑ –        ↑       –  –        –      ↑ 
IL-18   –        ↑      ↑ ↑        –       ↑    –        –       –  –        –      ↑ 
IL-33 –        –      – –        –       ↑ –        ↑       –  –        ↓      ↑ 
 
 
‘–‘ denotes no change 
 
 IL-1α IL-1β IL-18   IL-33 IL-
1RA 
IL-
18BP 
ST2 IL-1RaCP 
Placenta ↑ ↑ ↑ ↑ ↑ – ↓ ↓ 
Choriodecidua ↑ ↑ ↑ ↑ ↑ – – – 
Amnion  – ↑ – – ↓ – – ↓ 
Ac  
